Clin Psychopharmacol Neurosci.
2018 Nov;16(4):461-468. 10.9758/cpn.2018.16.4.461.
Predictors of Cognitive Improvement during 12 Weeks of Antidepressant Treatment in Patients with Major Depressive Disorder
- Affiliations
-
- 1Department of Psychiatry, Naju National Hospital, Naju, Korea.
- 2Department of Psychiatry, Chonnam National University Medical School, Gwangju, Korea. jmkim@chonnam.ac.kr
- 3Department of Psychiatry, Sungkyunkwan University School of Medicine, Seoul, Korea.
- KMID: 2428975
- DOI: http://doi.org/10.9758/cpn.2018.16.4.461
Abstract
OBJECTIVE
Cognitive disturbance is one of the major symptoms of depression and may be improved by treatment with antidepressants. This study aimed to investigate the predictors of cognitive improvement in patients with major depressive disorder (MDD) who were taking antidepressants.
METHODS
This study included 86 patients with MDD who completed 12 weeks of antidepressant monotherapy. Cognitive symptoms were assessed using the Perceived Deficits Questionnaire-Korean version (PDQ-K), which addresses four domains of cognitive functioning (attention/concentration, retrospective memory, prospective memory, and organization/planning) and was administered at study entry and at the 12-week end point. A variety of demographic, clinical, and treatment-related variables were evaluated as predictors of changes in total and domain scores.
RESULTS
All PDQ-K domains showed significant improvement after 12 weeks of antidepressant treatment. More severe initial depressive symptoms, fewer sick-leave days at study entry, and reduced use of concomitant anxiolytics/hypnotics during treatment were significantly associated with greater cognitive improvement.
CONCLUSION
Cognitive symptoms are more responsive to antidepressant treatment in patients with severe MDD. Reduced use of anxiolytics and hypnotics could improve the cognitive functioning of patients with MDD taking antidepressants.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The Effects of Cognitive Therapy in Major Depressive Disorder
- Current Update on Transcranial Direct Current Stimulation as Treatment for Major Depressive Disorder
- Cognitive Dysfunction and Improvement after Antidepressant Treatment in Patients with Non-Psychotic Major Depressive Disorder in Mild to Moderate Severity: A Prospective Study
- Alterations in Serum BDNF and GDNF Levels after 12 Weeks of Antidepressant Treatment in Female Outpatients with Major Depressive Disorder
- Adherence to Antidepressants in Korean Elderly Patients with Major Depressive Disorder
